» Articles » PMID: 20174493

Status Epilepticus

Overview
Specialty Neurology
Date 2010 Feb 23
PMID 20174493
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Status epilepticus (SE) is a medical emergency associated with significant morbidity and mortality. SE is defined as a continuous seizure lasting more than 30 min, or two or more seizures without full recovery of consciousness between any of them. Based on recent understanding of the pathophysiology, it is now considered that any seizure that lasts more than 5 min probably needs to be treated as SE. GABAergic mechanisms play a crucial role in terminating seizures. When the seizure persists, GABA-mediated mechanisms become ineffective and several other putative mechanisms of seizure suppression have been recognized. Early treatment of SE with benzodiazepines, followed if necessary by fosphenytoin administration, is the most widely followed strategy. About a third of patients with SE may have persistent seizures refractory to the first-line medications. They require aggressive management with second-line medications such as barbiturates, propofol, or other agents. In developing countries where facilities for assisted ventilation are not readily available, it may be helpful to use nonsedating antiepileptic drugs (such as sodium valproate, levetiracetam, or topiramate) at this stage. It is important to recognize SE and institute treatment as early as possible in order to avoid a refractory state. It is equally important to attend to the general condition of the patient and to ensure that the patient is hemodynamically stable. This article reviews current knowledge regarding the management of convulsive SE in adults.

Citing Articles

Virus-Induced Epilepsy vs. Epilepsy Patients Acquiring Viral Infection: Unravelling the Complex Relationship for Precision Treatment.

Costa B, Vale N Int J Mol Sci. 2024; 25(7).

PMID: 38612542 PMC: 11011490. DOI: 10.3390/ijms25073730.


Propofol-Related Infusion Syndrome in a Child With Refractory Status Epilepticus: Successful Resuscitation With Veno-Arterial Extracorporeal Membrane Oxygenation, Continuous Renal Replacement Therapy, and Therapeutic Plasma Exchange.

Calvano J, Paluska M, Armijo A, Petersen T, Soneru C, Broman A Cureus. 2023; 15(10):e47866.

PMID: 37908691 PMC: 10613782. DOI: 10.7759/cureus.47866.


Delayed tezampanel and caramiphen treatment but not midazolam protects against long-term neuropathology after soman exposure.

Figueiredo T, Aroniadou-Anderjaska V, Apland J, Rossetti K, Braga M Exp Biol Med (Maywood). 2023; 248(7):612-623.

PMID: 37300407 PMC: 10350803. DOI: 10.1177/15353702231171911.


Epilepsy Characteristics in Neurodevelopmental Disorders: Research from Patient Cohorts and Animal Models Focusing on Autism Spectrum Disorder.

Chakraborty S, Parayil R, Mishra S, Nongthomba U, Clement J Int J Mol Sci. 2022; 23(18).

PMID: 36142719 PMC: 9501968. DOI: 10.3390/ijms231810807.


An aqueous extract of Syzygium cumini protects against kainate-induced status epilepticus and amnesia: evidence for antioxidant and anti-inflammatory intervention.

Kandeda A, Nodeina S, Mabou S Metab Brain Dis. 2022; 37(7):2581-2602.

PMID: 35916986 DOI: 10.1007/s11011-022-01052-y.


References
1.
Naritoku D, Sinha S . Prolongation of midazolam half-life after sustained infusion for status epilepticus. Neurology. 2000; 54(6):1366-8. DOI: 10.1212/wnl.54.6.1366. View

2.
Ramael S, Daoust A, Otoul C, Toublanc N, Troenaru M, Lu Z . Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia. 2006; 47(7):1128-35. DOI: 10.1111/j.1528-1167.2006.00586.x. View

3.
Bleck T . Management approaches to prolonged seizures and status epilepticus. Epilepsia. 1999; 40 Suppl 1:S59-63; discussion S64-6. DOI: 10.1111/j.1528-1157.1999.tb00880.x. View

4.
GASTAUT H . Clinical and electroencephalographical classification of epileptic seizures. Epilepsia. 1970; 11(1):102-13. DOI: 10.1111/j.1528-1157.1970.tb03871.x. View

5.
Alldredge B, GELB A, Isaacs S, Corry M, Allen F, Ulrich S . A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001; 345(9):631-7. DOI: 10.1056/NEJMoa002141. View